Clinical trials
Type 2 Diabetes Patients clinical trials
Below are recruiting type 2 diabetes patients clinical trials, each written for real people, not researchers. We’re tracking 574 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05427084RecruitingPhase 2/Phase 3
Canagliflozin to reduce inflammation in heart artery disease
This trial tests canagliflozin to see if it lowers “vascular inflammation” in people with diabetes and stable coronary artery disease. It may help reduce harmful inflammation signals that can raise future heart risk.
Ottawa, OntarioAges 18 years+ - NCT05168605Recruiting
Targeted home visits for adults with diabetes and high blood pressure
This study tests whether tailored visits from a care team at your home can improve ongoing health problems from high blood pressure and poorly controlled blood sugar. It may help you by making care easier to follow and more personalized to your daily life.
Dallas, TexasAges 18–60 - NCT04943861Recruiting
Study on HIV and food insecurity support
This study is looking at food insecurity in adults living with HIV. It may help improve understanding of the barriers to healthy living and guide better support for people affected by HIV.
Winston-Salem, North CarolinaAges 18 years+ - NCT04326192Recruiting
Spinal cord stimulation to reduce stubborn back and leg pain
This trial tests whether spinal cord stimulation (a treatment where a device sends mild signals to the spinal cord) can improve persistent nerve-type back and leg pain. It is mainly for adults who are already planning to try spinal cord stimulation but have not tried it before.
Portland, OregonAges 21–70 - NCT06981234RecruitingPhase 2
Acetazolamide for type 1 diabetes
This trial tests whether a medicine called acetazolamide (used for altitude sickness) can help people with type 1 diabetes. It compares how your body responds while on the drug versus a placebo, using a crossover design so everyone gets both treatments.
La Jolla, CaliforniaAges 18 years+ - NCT06043245Enrolling by invitation
Diabetes remission and weight loss surgery
This trial tests whether a specific type of weight loss surgery can help people with type 2 diabetes stop needing diabetes medication. It is for people with a very high body mass index (BMI over 45) who are currently on diabetes pills or insulin.
L'Hospitalet de Llobregat, BarcelonaAges 18–60 - NCT07211126Recruiting
Control-IQ Study: Quality of Life with Type 1 Diabetes in France
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
AgenAges 6 years+ - NCT05593081Recruiting
Study of sudden type 1 diabetes after rapid symptom onset
This trial studies people who develop severe, fast-onset “type 1 diabetes” with body-wide stress (ketosis/ketoacidosis) soon after symptoms start. It aims to better understand this condition and how to care for it early.
Quanzhou, FujianAges Any age - NCT07611721Recruiting
Testing a glucose monitor in critically ill surgery patients
This study tests whether a wearable glucose monitor (Dexcom G7) works well in patients in intensive care after major abdominal surgery or organ transplant who need insulin therapy. The monitor measures blood sugar continuously to help doctors manage insulin doses more safely.
PragueAges 18 years+ - NCT06549400Enrolling by invitationPhase 3
Study on long-term safety of mexiletine for myotonic dystrophy
This study tests if a daily capsule of mexiletine is safe and helpful over 26 weeks for people with myotonic dystrophy type 1 or 2. It's for people who finished a previous related study and want to continue treatment.
LeuvenAges 16 years+ - NCT06523400RecruitingPhase 3
Mexiletine for myotonic dystrophy types 1 and 2
This trial tests a once-daily drug called mexiletine PR to see if it can help reduce muscle stiffness (myotonia) in people with myotonic dystrophy type 1 or 2. It may be a good option if you have a confirmed genetic diagnosis and are at least 16 years old.
LeuvenAges 16 years+ - NCT07503028Enrolling by invitationEarly Phase 1
Stem cell therapy for severe low blood sugar in diabetes
This trial tests a new treatment made from stem cells that may help people with diabetes who have dangerous low blood sugar episodes. It aims to see if these cells can replace some of the pancreas function and prevent severe hypoglycemia.
Hefei, AnhuiAges 18–70 - NCT07043426Recruiting
Diabetes care support for social needs
This study tests if connecting people with type 2 diabetes who have high A1C levels (9% or more) to community resources for social needs (like food or housing) can help improve their diabetes control. It aims to see if addressing life challenges outside the clinic helps lower blood sugar.
Boston, MassachusettsAges 18 years+ - NCT06305208Recruiting
UK registry for weight loss endoscopy procedures
This study collects information from patients in the UK who have a weight loss procedure done through an endoscope (a thin tube down the throat). It helps doctors learn more about how well these procedures work and how safe they are.
LondonAges 18–99 - NCT03323216Recruiting
Testing heart-related blood markers in people with diabetes and heart failure
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
Aachen, North Rhine-WestphaliaAges 18 years+ - NCT07684144RecruitingPhase 3
Long-term study of a weight-loss medication for people who completed an earlier trial
This study tests the long-term effects of a medication called maridebart cafraglutide for weight management. It is for people who already completed a 72-week study of this drug and want to continue treatment.
Gilbert, ArizonaAges 18–99 - NCT07678671Enrolling by invitation
Blood sugar control with a health education program
This study tests whether a simple educational program called Ask Me 3 helps people with type 2 diabetes better control their blood sugar. It may be a good fit if you get your diabetes care at Hospital Clínica Nova and want to learn more about managing your condition.
San Nicolás de los Garza, Nuevo LeónAges 18–80 - NCT06591286Recruiting
Real-time CGM for blood sugar after hospital discharge
This trial tests whether using a continuous glucose monitor (CGM) when you leave the hospital helps control blood sugar better. If you have type 2 diabetes and use insulin, you may be able to join.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05165706Recruiting
Study of how obesity affects insulin resistance over time
This study follows adults over time to understand how weight and body chemistry relate to insulin resistance. It may help researchers learn why insulin resistance happens and what could prevent or improve it.
Stanford, CaliforniaAges 35–65 - NCT06638567Recruiting
Comparing insulin methods after surgery for type 2 diabetes
This trial tests two ways to give insulin after gastrointestinal or vascular surgery to see which one leads to fewer wound infections. It may help if you have type 2 diabetes and are having one of these surgeries.
AmsterdamAges 18 years+ - NCT07360938Recruiting
How inflammation affects drug processing
This study looks at how inflammation from conditions like diabetes, IBD, or kidney disease affects the way drugs work in the body. It may help improve dosing and safety for patients with these conditions.
Indianapolis, IndianaAges 12–99 - NCT07317102Recruiting
Omnipod 5 study in France: real-world results
This study is testing how well the Omnipod 5 insulin pump works in everyday life for people with type 1 diabetes. It's for people who are just starting to use this pump, so doctors can see how it helps manage blood sugar in real-world settings.
AngersAges 2 years+ - NCT06665815Recruiting
Screening close family for type 1 diabetes risk
This study screens close family members of people with type 1 diabetes for early signs of the condition. A simple blood test looks for special markers (autoantibodies) that can show if the immune system is starting to attack the pancreas. Finding these markers early may help doctors prevent or delay the onset of diabetes.
Petah TikvaAges 2–45 - NCT07065383Recruiting
Testing a drug and exercise for heart and muscle fat in diabetes
This study tests if a weekly injection (semaglutide) combined with an exercise program can help reduce fat stored in the heart and muscles in people with type 2 diabetes. It may improve how well your body handles sugar and lowers your risk for heart problems.
Aberdeen, AberdeenshireAges 20–75
Hear when a new Type 2 Diabetes Patients trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 2 diabetes patients?
- Yes. Clin2 currently lists 574 recruiting type 2 diabetes patients studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 2 diabetes patients trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 2 diabetes patients trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.